Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - MEDICAL ACTION INDUSTRIES INC | d295166d8k.htm |
500 Expressway Drive South, Brentwood, NY 11717
Phone: 631.231.4600
www.medical-action.com
EXHIBIT 99.1
| CONTACT: |
Charles L. Kelly – Chief Financial Officer MEDICAL ACTION INDUSTRIES INC. (631) 231-4600 | |
FOR IMMEDIATE RELEASE
MEDICAL ACTION INDUSTRIES REPORTS
THIRD QUARTER 2012 RESULTS
BRENTWOOD, NY, February 1, 2012 – Medical Action Industries Inc. (NASDAQ/MDCI), a leading supplier of medical and surgical disposable products, today reported results for the fiscal 2012 third quarter ended December 31, 2011.
Net sales for the third quarter of fiscal 2012 were $112,969,000, an increase of $8,492,000, or 8%, compared to the $104,477,000 in net sales reported for the comparable prior year period. Net sales for the third quarter of fiscal 2012 included $34,905,000 in custom procedure tray sales generated by AVID Medical Inc. (“AVID”), which was acquired by Medical Action on August 27, 2010. Excluding sales of custom procedure trays, Medical Action’s net sales for the third quarter of fiscal 2012 were $78,064,000, representing an increase of $6,691,000, or 9%, from the comparable prior year period.
Net income for the third quarter of fiscal 2012 was $1,825,000 or $0.11 per basic and diluted share, versus the $2,304,000, or $0.14 per basic and diluted share, reported for the comparable prior year period.
Net sales for the nine months ended December 31, 2011 were $329,097,000, an increase of $71,876,000 or 28% from the $257,221,000 in net sales reported for the comparable nine months of fiscal 2011. Net sales for the nine months ended December 31, 2011 included $102,987,000 in custom procedure tray sales generated by AVID. Excluding sales of custom procedure trays, Medical Action’s net sales for the nine months ended December 31, 2011 were $226,110,000, representing an increase of $16,131,000 or 8% from the comparable prior year period.
Net income for the nine months ended December 31, 2011 was $2,642,000 or $0.16 per basic and diluted share, versus the $3,269,000 or $0.20 per basic and diluted share reported for the comparable prior year period. Included in net income for the nine months ended December 31, 2011 was an extraordinary pre-tax gain of $700,000 or $0.03 per basic and diluted share (net of applicable tax expense) due to an insurance settlement related to inventories damaged as a result of weather-related flooding. Net income for the nine months ended December 31, 2010 included an extraordinary pre-tax loss of $1,455,000 or $0.05 per basic and diluted share (net of applicable tax benefit) due to inventories damaged as a result of weather-related flooding and one-time pre-tax transaction costs of $1,335,000 related to the acquisition of AVID.
“We continue to focus on organic growth and enhancing our product and service offerings,” said Chief Executive Officer and President, Paul D. Meringolo. “Net sales have increased from the comparable prior year period and sequentially. Persistent volatility in raw material costs, particularly resin and cotton, continue to influence our gross margins. We are managing through this period of volatility by continually reviewing our pricing strategies across our product lines, minimizing product sourcing costs and operating expenses.”
2
Medical Action invites its shareholders and other interested parties to attend its conference call at 10 a.m. (ET) on February 1, 2012. You may participate in the conference call by calling (888) 868-9080 (domestic) or (973) 935-8511 (international); conference ID #40049844. The conference call will be simultaneously web cast on our website: www.medical-action.com. The complete call and discussion will be available for replay on our website beginning at 11 a.m. (ET) on February 1, 2012.
Medical Action is a diversified manufacturer and distributor of disposable medical devices and a leader in many of the markets where it competes. Its products are marketed primarily to acute care facilities in domestic and certain international markets. The Company has expanded its target market to include physician, dental and veterinary offices, out-patient surgery centers, long-term care facilities and laboratories. Medical Action’s products are marketed nationally by its direct sales personnel and extensive network of healthcare distributors. The Company has preferred vendor agreements with national and regional distributors, as well as sole and multi-source agreements with group purchasing organizations. Medical Action’s common stock trades on the NASDAQ Global Select Market under the symbol MDCI and is included in the Russell 2000 Index.
# # # #
This news release contains forward-looking statements that involve risks and uncertainties regarding Medical Action’s operations and future results. Please see the Company’s filings with the Securities and Exchange Commission, including, without limitation, the Company’s Form 10-K and Form 10-Qs, which identify specific factors that would cause actual results or events to differ materially from those described in the forward-looking statements.
3
MEDICAL ACTION INDUSTRIES INC.
CONSOLIDATED BALANCE SHEETS
(dollars in thousands, except share and per share data)
| December 31, | March 31, | |||||||
| 2011 | 2011 | |||||||
| (Unaudited) | ||||||||
| ASSETS |
||||||||
| CURRENT ASSETS: |
||||||||
| Cash and cash equivalents |
$ | 1,003 | $ | 1,691 | ||||
| Accounts receivable, less allowance for doubtful accounts of $818 at December 31, 2011 and $804 at March 31, 2011 |
35,728 | 32,330 | ||||||
| Inventories, net |
55,650 | 54,674 | ||||||
| Prepaid expenses |
2,258 | 1,702 | ||||||
| Deferred income taxes |
3,008 | 2,801 | ||||||
| Prepaid income taxes |
318 | 1,938 | ||||||
| Other current assets |
1,709 | 1,637 | ||||||
|
|
|
|
|
|||||
| Total current assets |
99,674 | 96,773 | ||||||
| Property, plant and equipment, net |
50,205 | 53,901 | ||||||
| Goodwill, net |
108,764 | 108,652 | ||||||
| Other intangible assets, net |
39,882 | 41,860 | ||||||
| Other assets, net |
2,940 | 3,319 | ||||||
|
|
|
|
|
|||||
| Total assets |
$ | 301,465 | $ | 304,505 | ||||
|
|
|
|
|
|||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
| CURRENT LIABILITIES: |
||||||||
| Accounts payable |
$ | 14,272 | $ | 17,069 | ||||
| Accrued expenses |
22,578 | 22,235 | ||||||
| Current portion of capital lease obligation |
121 | 92 | ||||||
| Current portion of long-term debt |
16,000 | 16,360 | ||||||
|
|
|
|
|
|||||
| Total current liabilities |
52,971 | 55,756 | ||||||
| Deferred income taxes |
27,956 | 27,956 | ||||||
| Capital lease obligation, less current portion |
13,690 | 13,790 | ||||||
| Long-term debt, less current portion |
55,470 | 58,776 | ||||||
|
|
|
|
|
|||||
| Total liabilities |
150,087 | 156,278 | ||||||
| STOCKHOLDERS’ EQUITY: |
||||||||
| Common stock - 40,000,000 shares authorized, $.001 par value; issued and outstanding 16,390,628 shares at December 31, 2011 and 16,383,128 shares at March 31, 2011 |
16 | 16 | ||||||
| Additional paid-in capital |
34,308 | 33,799 | ||||||
| Accumulated other comprehensive loss |
(437 | ) | (437 | ) | ||||
| Retained earnings |
117,491 | 114,849 | ||||||
|
|
|
|
|
|||||
| Total stockholders’ equity |
151,378 | 148,227 | ||||||
|
|
|
|
|
|||||
| Total liabilities and stockholders’ equity |
$ | 301,465 | $ | 304,505 | ||||
|
|
|
|
|
|||||
4
MEDICAL ACTION INDUSTRIES INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(dollars in thousands, except per share data)
| Three Months Ended December 31, |
Nine Months Ended December 31, |
|||||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||
| (Unaudited) | (Unaudited) | |||||||||||||||
| Net sales |
$ | 112,969 | $ | 104,477 | $ | 329,097 | $ | 257,221 | ||||||||
| Cost of sales |
95,824 | 86,055 | 278,294 | 211,415 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Gross profit |
17,145 | 18,422 | 50,803 | 45,806 | ||||||||||||
| Selling, general and administrative expenses |
13,327 | 13,551 | 44,110 | 37,299 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Operating income |
3,818 | 4,871 | 6,693 | 8,507 | ||||||||||||
| Interest expense, net |
1,174 | 1,116 | 3,421 | 1,742 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Income before income taxes and extraordinary item |
2,644 | 3,755 | 3,272 | 6,765 | ||||||||||||
| Income tax expense |
819 | 1,451 | 1,070 | 2,600 | ||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Income before extraordinary item |
1,825 | 2,304 | 2,202 | 4,165 | ||||||||||||
| Extraordinary gain (loss), net of applicable taxes |
— | — | 440 | (896 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income |
$ | 1,825 | $ | 2,304 | $ | 2,642 | $ | 3,269 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Per share basis: |
||||||||||||||||
| Basic |
||||||||||||||||
| Income before extraordinary item |
$ | 0.11 | $ | 0.14 | $ | 0.13 | $ | 0.25 | ||||||||
| Extraordinary gain (loss), net of applicable taxes |
$ | — | $ | — | $ | 0.03 | $ | (0.05 | ) | |||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income |
$ | 0.11 | $ | 0.14 | $ | 0.16 | $ | 0.20 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Diluted |
||||||||||||||||
| Income before extraordinary item |
$ | 0.11 | $ | 0.14 | $ | 0.13 | $ | 0.25 | ||||||||
| Extraordinary gain (loss), net of applicable taxes |
$ | — | $ | — | $ | 0.03 | $ | (0.05 | ) | |||||||
|
|
|
|
|
|
|
|
|
|||||||||
| Net income |
$ | 0.11 | $ | 0.14 | $ | 0.16 | $ | 0.20 | ||||||||
|
|
|
|
|
|
|
|
|
|||||||||
5
MEDICAL ACTION INDUSTRIES INC.
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY
NINE MONTHS ENDED DECEMBER 31, 2011
(Unaudited)
(dollars in thousands, except share data)
| Common Stock | Additional Paid-In Capital |
Accumulated Other Comprehensive Loss |
Retained Earnings |
Total Stockholders’ Equity |
||||||||||||||||||||
| Shares | Amount | |||||||||||||||||||||||
| Balance at April 1, 2011 |
16,383,128 | $ | 16 | $ | 33,799 | $ | (437 | ) | $ | 114,849 | $ | 148,227 | ||||||||||||
| Exercise of stock options |
7,500 | — | 20 | 20 | ||||||||||||||||||||
| Amortization of deferred compensation |
15 | 15 | ||||||||||||||||||||||
| Tax benefit from vesting of restricted stock and exercise of stock options |
19 | 19 | ||||||||||||||||||||||
| Stock-based compensation |
455 | 455 | ||||||||||||||||||||||
| Net income |
2,642 | 2,642 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Balance at December 31, 2011 |
16,390,628 | $ | 16 | $ | 34,308 | $ | (437 | ) | $ | 117,491 | $ | 151,378 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
6
MEDICAL ACTION INDUSTRIES INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(dollars in thousands)
| Nine Months Ended December 31, |
||||||||
| 2011 | 2010 | |||||||
| (Unaudited) | ||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES: |
||||||||
| Net income |
$ | 2,642 | $ | 3,269 | ||||
| Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
| Extraordinary (gain) loss |
(700 | ) | 1,455 | |||||
| Depreciation |
4,394 | 3,960 | ||||||
| Amortization |
3,264 | 2,321 | ||||||
| Provision for doubtful accounts |
39 | 9 | ||||||
| Deferred income taxes |
— | (45 | ) | |||||
| Stock-based compensation |
470 | 589 | ||||||
| Excess tax liability from stock-based compensation |
(207 | ) | — | |||||
| Loss on disposal of property and equipment |
— | 20 | ||||||
| Tax benefit from vesting of restricted stock and exercise of stock options |
19 | 79 | ||||||
| Changes in operating assets and liabilities: |
||||||||
| Accounts receivable |
(3,652 | ) | 303 | |||||
| Inventories |
(998 | ) | (16,372 | ) | ||||
| Prepaid expenses and other current assets |
72 | 423 | ||||||
| Other assets |
(907 | ) | (1,933 | ) | ||||
| Accounts payable |
(2,797 | ) | 583 | |||||
| Prepaid income taxes |
1,620 | 8 | ||||||
| Accrued expenses |
343 | 4,955 | ||||||
|
|
|
|
|
|||||
| Net cash provided by (used in) operating activities |
3,602 | (376 | ) | |||||
|
|
|
|
|
|||||
| CASH FLOWS FROM INVESTING ACTIVITIES: |
||||||||
| Purchase price and related acquisition costs |
125 | (62,525 | ) | |||||
| Purchases of property, plant and equipment |
(701 | ) | (2,914 | ) | ||||
| Proceeds from sale of property and equipment |
3 | 4 | ||||||
|
|
|
|
|
|||||
| Net cash used in investing activities |
(573 | ) | (65,435 | ) | ||||
|
|
|
|
|
|||||
| CASH FLOWS FROM FINANCING ACTIVITIES: |
||||||||
| Proceeds from revolving line of credit and long-term borrowings |
74,217 | 155,380 | ||||||
| Principal payments on revolving line of credit and long-term borrowings |
(77,883 | ) | (90,428 | ) | ||||
| Principal payments on capital lease obligation |
(71 | ) | (20 | ) | ||||
| Proceeds from exercise of stock options |
20 | 152 | ||||||
|
|
|
|
|
|||||
| Net cash (used in) provided by financing activities |
(3,717 | ) | 65,084 | |||||
|
|
|
|
|
|||||
| Net decrease in cash and cash equivalents |
(688 | ) | (727 | ) | ||||
| Cash and cash equivalents at beginning of period |
1,691 | 5,641 | ||||||
|
|
|
|
|
|||||
| Cash and cash equivalents at end of period |
$ | 1,003 | $ | 4,914 | ||||
|
|
|
|
|
|||||
| Supplemental disclosures: |
||||||||
| Interest paid |
$ | 2,347 | $ | 1,189 | ||||
| Income taxes (refunded) paid |
$ | (491 | ) | $ | 1,947 | |||
7